Prunella vulgaris Extract Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating Androgen Levels, Cell Proliferation, and Apoptosis
Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men. Prunella vulgaris L. (PV), a perennial herbaceous plant native to Europe and Asia, has anti-inflammatory, antioxidant, and antimicrobial effects. In this study, we determined the effe...
Saved in:
Published in: | Pharmaceuticals (Basel, Switzerland) Vol. 17; no. 11; p. 1516 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Basel
MDPI AG
11-11-2024
MDPI |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men. Prunella vulgaris L. (PV), a perennial herbaceous plant native to Europe and Asia, has anti-inflammatory, antioxidant, and antimicrobial effects. In this study, we determined the effect of PV extract on the development of BPH. Methods: Rats were treated via a daily hypodermic injection of testosterone propionate (TP; 3 mg/kg) for 4 weeks. Groups of BPH rats were treated with or without PV (60 or 80 mg/kg) by oral gavage. Results: In BPH model rats, PV considerably reduced their relative prostate weight and serum concentrations of dihydrotestosterone (DHT) and testosterone. The TP-induced increases in epithelial thickness in the prostate, proliferating cell nuclear antigen (PCNA) expression, and cyclin D1 expression were remarkably reduced, whereas terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)-positive cells and cleaved caspase-3 levels were increased, in PV-treated rats compared to BPH rats. The mRNA expression levels of growth factors, such as transforming growth factor-β (TGF-β), fibroblast growth factor (FGF), and insulin-like growth factor (IGF-2), were significantly reduced in PV-treated rats. Mechanistically, the TP-induced activation of c-Jun N-terminal kinase (JNK) was reduced by PV administration. Conclusions: These results designate that PV effectively ameliorates the development of testosterone-induced BPH through anti-androgenic, anti-proliferative, and pro-apoptotic activities, suggesting that it could be a potential therapeutic substance for BPH. |
---|---|
AbstractList | Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men.
Prunella vulgaris
L. (PV), a perennial herbaceous plant native to Europe and Asia, has anti-inflammatory, antioxidant, and antimicrobial effects. In this study, we determined the effect of PV extract on the development of BPH. Methods: Rats were treated via a daily hypodermic injection of testosterone propionate (TP; 3 mg/kg) for 4 weeks. Groups of BPH rats were treated with or without PV (60 or 80 mg/kg) by oral gavage. Results: In BPH model rats, PV considerably reduced their relative prostate weight and serum concentrations of dihydrotestosterone (DHT) and testosterone. The TP-induced increases in epithelial thickness in the prostate, proliferating cell nuclear antigen (PCNA) expression, and cyclin D1 expression were remarkably reduced, whereas terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)-positive cells and cleaved caspase-3 levels were increased, in PV-treated rats compared to BPH rats. The mRNA expression levels of growth factors, such as transforming growth factor-β (TGF-β), fibroblast growth factor (FGF), and insulin-like growth factor (IGF-2), were significantly reduced in PV-treated rats. Mechanistically, the TP-induced activation of c-Jun N-terminal kinase (JNK) was reduced by PV administration. Conclusions: These results designate that PV effectively ameliorates the development of testosterone-induced BPH through anti-androgenic, anti-proliferative, and pro-apoptotic activities, suggesting that it could be a potential therapeutic substance for BPH. Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men. Prunella vulgaris L. (PV), a perennial herbaceous plant native to Europe and Asia, has anti-inflammatory, antioxidant, and antimicrobial effects. In this study, we determined the effect of PV extract on the development of BPH. Methods: Rats were treated via a daily hypodermic injection of testosterone propionate (TP; 3 mg/kg) for 4 weeks. Groups of BPH rats were treated with or without PV (60 or 80 mg/kg) by oral gavage. Results: In BPH model rats, PV considerably reduced their relative prostate weight and serum concentrations of dihydrotestosterone (DHT) and testosterone. The TP-induced increases in epithelial thickness in the prostate, proliferating cell nuclear antigen (PCNA) expression, and cyclin D1 expression were remarkably reduced, whereas terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)-positive cells and cleaved caspase-3 levels were increased, in PV-treated rats compared to BPH rats. The mRNA expression levels of growth factors, such as transforming growth factor-β (TGF-β), fibroblast growth factor (FGF), and insulin-like growth factor (IGF-2), were significantly reduced in PV-treated rats. Mechanistically, the TP-induced activation of c-Jun N-terminal kinase (JNK) was reduced by PV administration. Conclusions: These results designate that PV effectively ameliorates the development of testosterone-induced BPH through anti-androgenic, anti-proliferative, and pro-apoptotic activities, suggesting that it could be a potential therapeutic substance for BPH. |
Author | Ji, Hyo-Seong Baek, Eun-Bok Jang, Mi-Ran Kumbukgahadeniya, Poornima Song, Jun-Yeop Hong, Eun-Ju Kwak, Youn-Gil Kwun, Hyo-Jung |
AuthorAffiliation | 2 Huons Foodience Co., Ltd., 19, Insam Gwangjang ro, Geumsan eup, Geumsan gun 32724, Republic of Korea; kyg@huonsfoodience.com (Y.-G.K.); rose86mr@huonsfoodience.com (M.-R.J.); hsji@huonsfoodience.com (H.-S.J.) 1 Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea; poornima.lakshini93@gmail.com (P.K.); baekeunbok@hanmail.net (E.-B.B.); bioeun59@naver.com (E.-J.H.); qldqld0610@gmail.com (J.-Y.S.) |
AuthorAffiliation_xml | – name: 1 Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea; poornima.lakshini93@gmail.com (P.K.); baekeunbok@hanmail.net (E.-B.B.); bioeun59@naver.com (E.-J.H.); qldqld0610@gmail.com (J.-Y.S.) – name: 2 Huons Foodience Co., Ltd., 19, Insam Gwangjang ro, Geumsan eup, Geumsan gun 32724, Republic of Korea; kyg@huonsfoodience.com (Y.-G.K.); rose86mr@huonsfoodience.com (M.-R.J.); hsji@huonsfoodience.com (H.-S.J.) |
Author_xml | – sequence: 1 givenname: Poornima orcidid: 0009-0009-2486-1562 surname: Kumbukgahadeniya fullname: Kumbukgahadeniya, Poornima – sequence: 2 givenname: Eun-Bok orcidid: 0000-0001-7279-7774 surname: Baek fullname: Baek, Eun-Bok – sequence: 3 givenname: Eun-Ju surname: Hong fullname: Hong, Eun-Ju – sequence: 4 givenname: Jun-Yeop orcidid: 0009-0009-8358-0664 surname: Song fullname: Song, Jun-Yeop – sequence: 5 givenname: Youn-Gil surname: Kwak fullname: Kwak, Youn-Gil – sequence: 6 givenname: Mi-Ran surname: Jang fullname: Jang, Mi-Ran – sequence: 7 givenname: Hyo-Seong surname: Ji fullname: Ji, Hyo-Seong – sequence: 8 givenname: Hyo-Jung surname: Kwun fullname: Kwun, Hyo-Jung |
BookMark | eNpVkd1q3DAQhUVJIT_tTZ5AkLsSN56VbXmvwnZJm8BCQ0mvhX5GjoJWciV7yb5JHzcKCU0DghGcmfNJZ47JQYgBCTmF-itjy_pivAcOAC10H8gRNIum6hcNP_jvfkiOc36o65ZDA0fk722aA3ov6W72g0wu06vHKUk90dUWvYtJTpjpHeYp5glTwVU3wcwaDf2GwQ2B3qaiyMlper0fMY1eZiep2tNfOMy-CGGgq2BSHDDQDe7Q53O6LsznSe8sFoSL4ZzKYOhqjGMhufyJfLTSZ_z8Wk_I7-9Xd-vravPzx816tak0tG1XKQOKSWl026nOdhZUay1wpZGBbaCpbc96q4EtuAEu66Xq6x606RBASavYCbl88R1ntUWjMZTfezEmt5VpL6J04r0S3L0Y4k6UlJe8431xOHt1SPHPXIISD3FOoTxaMGDlAO956fry0qVLXDmh_YeAWjzvTrztjj0B9niTMQ |
Cites_doi | 10.1002/pros.2990150506 10.1089/rej.2017.1971 10.3390/antiox10071014 10.1002/pros.21030 10.1097/MOU.0b013e328316c357 10.1345/aph.1A228 10.3390/antiox13080952 10.2174/1381612825666190313121608 10.1007/s11934-019-0917-1 10.5534/wjmh.230122 10.1111/cpr.12415 10.1248/bpb.b17-00468 10.1016/S0022-5347(17)36966-5 10.1016/j.phymed.2023.155048 10.1023/A:1026057402945 10.1007/s00345-002-0248-5 10.1590/S1677-55382010000500006 10.1016/j.diff.2011.06.001 10.4081/aiua.2019.4.205 10.1002/j.1939-4640.1991.tb00272.x 10.3390/molecules29081843 10.1158/0008-5472.CAN-07-0418 10.1007/s11934-008-0048-6 10.1210/jcem.86.2.7211 10.1016/S0090-4295(01)01299-7 10.1046/j.1365-2265.1997.1100922.x 10.3390/biom14020243 10.1016/S0022-5347(17)49698-4 10.2147/OTT.S374908 10.1016/j.cyto.2011.06.024 10.2174/092986706779010315 10.3390/cancers13051158 10.2147/NDT.S1612 10.1002/(SICI)1097-4652(199610)169:1<97::AID-JCP10>3.0.CO;2-L 10.4103/0976-7800.98811 10.5534/wjmh.200012 10.3390/ijms24065904 10.1016/j.ucl.2009.07.003 10.1038/nrdp.2016.31 10.56434/j.arch.esp.urol.20237609.79 10.3390/ijms25094843 10.1080/13685538.2016.1272101 10.1124/jpet.119.260216 10.1038/s41419-020-2317-3 10.1007/s43188-021-00114-0 10.1590/S1677-5538.IBJU.2015.01.15 10.3389/fimmu.2023.1196434 10.5567/pharmacologia.2013.441.448 10.3389/fphar.2022.903171 10.1046/j.1464-410x.2000.00874.x 10.3892/etm.2012.524 |
ContentType | Journal Article |
Copyright | 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2024 by the authors. 2024 |
Copyright_xml | – notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2024 by the authors. 2024 |
DBID | AAYXX CITATION 3V. 7XB 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO GNUQQ GUQSH M2O MBDVC PIMPY PQEST PQQKQ PQUKI PRINS Q9U 5PM |
DOI | 10.3390/ph17111516 |
DatabaseName | CrossRef ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central ProQuest Central Student Research Library Prep Research Library (ProQuest Database) Research Library (Corporate) Publicly Available Content Database (Proquest) (PQ_SDU_P3) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Research Library ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1424-8247 |
ExternalDocumentID | 10_3390_ph17111516 |
GeographicLocations | Europe |
GeographicLocations_xml | – name: Europe |
GrantInformation_xml | – fundername: Ministry of Agriculture, Food, and Rural Affairs (MAFRA) grantid: 1220453 |
GroupedDBID | --- 2WC 3V. 53G 5VS 8G5 AADQD AAFWJ AAYXX ABDBF ABUWG ACGFO ACIHN ADBBV AEAQA AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ CCPQU CITATION DIK DWQXO EBD ESX GNUQQ GROUPED_DOAJ GUQSH GX1 HH5 HYE IAO IHR ITC KQ8 M2O MK0 MODMG M~E OK1 P2P PGMZT PIMPY PQQKQ PROAC RIG RPM TUS 7XB 8FK M48 MBDVC PQEST PQUKI PRINS Q9U 5PM |
ID | FETCH-LOGICAL-c1556-bd1b3aadc56b6f6f1b5ff17bce31f4140f838fc1327d17a09b8081cd6e11bafb3 |
IEDL.DBID | RPM |
ISSN | 1424-8247 |
IngestDate | Wed Nov 27 05:24:31 EST 2024 Wed Nov 27 13:44:30 EST 2024 Wed Nov 13 12:46:43 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c1556-bd1b3aadc56b6f6f1b5ff17bce31f4140f838fc1327d17a09b8081cd6e11bafb3 |
ORCID | 0009-0009-2486-1562 0009-0009-8358-0664 0000-0001-7279-7774 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597678/ |
PQID | 3133131787 |
PQPubID | 2032350 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11597678 proquest_journals_3133131787 crossref_primary_10_3390_ph17111516 |
PublicationCentury | 2000 |
PublicationDate | 20241111 |
PublicationDateYYYYMMDD | 2024-11-11 |
PublicationDate_xml | – month: 11 year: 2024 text: 20241111 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | Basel |
PublicationPlace_xml | – name: Basel |
PublicationTitle | Pharmaceuticals (Basel, Switzerland) |
PublicationYear | 2024 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Traish (ref_31) 2020; 38 ref_50 Wang (ref_23) 2019; 25 Dvorkin (ref_56) 2002; 36 Wu (ref_55) 2012; 3 ref_54 Chen (ref_37) 2009; 69 Wijerathne (ref_51) 2017; 40 Busetto (ref_33) 2020; 91 Chatterjee (ref_6) 2003; 253 Chughtai (ref_1) 2016; 2 Lloyd (ref_7) 2019; 20 Khosravi (ref_43) 2001; 86 Wu (ref_47) 2011; 5 Blankstein (ref_15) 2016; 23 Barry (ref_3) 1992; 148 Lee (ref_30) 2024; 42 ref_25 ref_21 Asiedu (ref_29) 2017; 20 Fraile (ref_53) 2012; 2012 Zhang (ref_38) 2018; 21 Sukjamnong (ref_22) 2022; 38 ref_28 ref_27 ref_26 Correa (ref_42) 2015; 41 Isaacs (ref_9) 1989; 15 Lee (ref_49) 2022; 15 ref_35 ref_32 Facio (ref_18) 2010; 36 Quaresma (ref_16) 2019; 371 Caggia (ref_39) 2011; 56 Bartsch (ref_5) 2002; 19 Gong (ref_40) 2023; 120 Lambert (ref_11) 2008; 9 Gnanapragasam (ref_44) 2000; 86 Lawson (ref_10) 1997; 32 Kulig (ref_17) 2006; 13 Story (ref_46) 1996; 169 Sinowatz (ref_41) 2000; 15 Fan (ref_48) 2020; 11 Steers (ref_14) 2001; 58 Wong (ref_19) 2009; 19 Hegazi (ref_34) 2023; 76 Ney (ref_57) 2007; 3 Bushman (ref_4) 2009; 36 Rasool (ref_24) 2013; 4 McConnell (ref_8) 1991; 12 Laufer (ref_20) 2024; 163 Zhao (ref_52) 2018; 51 McLaren (ref_12) 2011; 82 Shrivastava (ref_13) 2012; 3 Ho (ref_45) 1997; 46 Berry (ref_2) 1984; 132 He (ref_36) 2007; 67 |
References_xml | – volume: 15 start-page: 33 year: 1989 ident: ref_9 article-title: Etiology and disease process of benign prostatic hyperplasia publication-title: Prostate doi: 10.1002/pros.2990150506 contributor: fullname: Isaacs – volume: 21 start-page: 313 year: 2018 ident: ref_38 article-title: Prunella vulgaris L. Exerts a Protective Effect Against Extrinsic Aging Through NF-κB, MAPKs, AP-1, and TGF-β/Smad Signaling Pathways in UVB-Aged Normal Human Dermal Fibroblasts publication-title: Rejuvenation Res. doi: 10.1089/rej.2017.1971 contributor: fullname: Zhang – ident: ref_35 doi: 10.3390/antiox10071014 – volume: 2012 start-page: 169170 year: 2012 ident: ref_53 article-title: MAP kinases and prostate cancer publication-title: J. Signal Transduct. contributor: fullname: Fraile – volume: 69 start-page: 1790 year: 2009 ident: ref_37 article-title: Prostasin regulates iNOS and cyclin D1 expression by modulating protease-activated receptor-2 signaling in prostate epithelial cells publication-title: Prostate doi: 10.1002/pros.21030 contributor: fullname: Chen – volume: 19 start-page: 7 year: 2009 ident: ref_19 article-title: Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: The best of both worlds publication-title: Curr. Opin. Urol. doi: 10.1097/MOU.0b013e328316c357 contributor: fullname: Wong – volume: 36 start-page: 1443 year: 2002 ident: ref_56 article-title: Herbs for benign prostatic hyperplasia publication-title: Ann. Pharmacother. doi: 10.1345/aph.1A228 contributor: fullname: Dvorkin – ident: ref_26 doi: 10.3390/antiox13080952 – volume: 25 start-page: 359 year: 2019 ident: ref_23 article-title: Prunella vulgaris: A comprehensive review of chemical constituents, pharmacological effects and clinical applications publication-title: Curr. Pharm. Des. doi: 10.2174/1381612825666190313121608 contributor: fullname: Wang – volume: 20 start-page: 54 year: 2019 ident: ref_7 article-title: Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation? publication-title: Curr. Urol. Rep. doi: 10.1007/s11934-019-0917-1 contributor: fullname: Lloyd – volume: 42 start-page: 600 year: 2024 ident: ref_30 article-title: The Role of Reactive Oxygen Species, Inflammation, and Endoplasmic Reticulum Stress Response in the Finasteride Protective Effect against Benign Prostate Hyperplasia publication-title: World J. Mens. Health doi: 10.5534/wjmh.230122 contributor: fullname: Lee – volume: 51 start-page: e12415 year: 2018 ident: ref_52 article-title: Finasteride accelerates prostate wound healing after thulium laser resection through DHT and AR signalling publication-title: Cell Prolif. doi: 10.1111/cpr.12415 contributor: fullname: Zhao – volume: 23 start-page: 10 year: 2016 ident: ref_15 article-title: BPH update: Medical versus interventional management publication-title: Can. J. Urol. contributor: fullname: Blankstein – volume: 40 start-page: 2125 year: 2017 ident: ref_51 article-title: Quisqualis indica improves benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.b17-00468 contributor: fullname: Wijerathne – volume: 5 start-page: 4218 year: 2011 ident: ref_47 article-title: Effects of sulfated polysaccharide extracted from Prunella vulgaris on endothelial cells publication-title: J. Med. Plants Res. contributor: fullname: Wu – volume: 148 start-page: 1549 year: 1992 ident: ref_3 article-title: The American Urological Association symptom index for benign prostatic hyperplasia publication-title: J. Urol. doi: 10.1016/S0022-5347(17)36966-5 contributor: fullname: Barry – volume: 120 start-page: 155048 year: 2023 ident: ref_40 article-title: Bushen Tongluo formula ameliorated testosterone propionate-induced benign prostatic hyperplasia in rats publication-title: Phytomedicine doi: 10.1016/j.phymed.2023.155048 contributor: fullname: Gong – volume: 253 start-page: 89 year: 2003 ident: ref_6 article-title: The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer publication-title: Mol. Cell. Biochem. doi: 10.1023/A:1026057402945 contributor: fullname: Chatterjee – volume: 163 start-page: 50 year: 2024 ident: ref_20 article-title: Phytotherapy and Natural Agents in Symptomatic Benign Prostatic Hyperplasia (BPH) publication-title: Harefuah contributor: fullname: Laufer – volume: 19 start-page: 413 year: 2002 ident: ref_5 article-title: Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia publication-title: World J. Urol. doi: 10.1007/s00345-002-0248-5 contributor: fullname: Bartsch – volume: 36 start-page: 563 year: 2010 ident: ref_18 article-title: Benign prostatic hyperplasia. Clinical treatment can complicate cataract surgery publication-title: Int. Braz. J. Urol. doi: 10.1590/S1677-55382010000500006 contributor: fullname: Facio – volume: 82 start-page: 237 year: 2011 ident: ref_12 article-title: Role of interleukins, IGF and stem cells in BPH publication-title: Differentiation doi: 10.1016/j.diff.2011.06.001 contributor: fullname: McLaren – volume: 91 start-page: 205 year: 2020 ident: ref_33 article-title: Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature publication-title: Arch. Ital. Urol. Androl. doi: 10.4081/aiua.2019.4.205 contributor: fullname: Busetto – volume: 12 start-page: 356 year: 1991 ident: ref_8 article-title: The pathophysiology of benign prostatic hyperplasia publication-title: J. Androl. doi: 10.1002/j.1939-4640.1991.tb00272.x contributor: fullname: McConnell – ident: ref_28 doi: 10.3390/molecules29081843 – volume: 67 start-page: 8188 year: 2007 ident: ref_36 article-title: Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-0418 contributor: fullname: He – volume: 9 start-page: 272 year: 2008 ident: ref_11 article-title: Growth factors in benign prostatic hyperplasia: Basic science implications publication-title: Curr. Urol. Rep. doi: 10.1007/s11934-008-0048-6 contributor: fullname: Lambert – volume: 86 start-page: 694 year: 2001 ident: ref_43 article-title: Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.86.2.7211 contributor: fullname: Khosravi – volume: 58 start-page: 17 year: 2001 ident: ref_14 article-title: 5α-reductase activity in the prostate publication-title: Urology doi: 10.1016/S0090-4295(01)01299-7 contributor: fullname: Steers – volume: 46 start-page: 145 year: 1997 ident: ref_45 article-title: Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia publication-title: Clin. Endocrinol. doi: 10.1046/j.1365-2265.1997.1100922.x contributor: fullname: Ho – ident: ref_50 doi: 10.3390/biom14020243 – volume: 132 start-page: 474 year: 1984 ident: ref_2 article-title: The development of human benign prostatic hyperplasia with age publication-title: J. Urol. doi: 10.1016/S0022-5347(17)49698-4 contributor: fullname: Berry – volume: 15 start-page: 963 year: 2022 ident: ref_49 article-title: Role of the JNK Pathway in Bladder Cancer publication-title: OncoTargets Ther. doi: 10.2147/OTT.S374908 contributor: fullname: Lee – volume: 56 start-page: 403 year: 2011 ident: ref_39 article-title: Modulation of YY1 and p53 expression by transforming growth factor-β3 in prostate cell lines publication-title: Cytokine doi: 10.1016/j.cyto.2011.06.024 contributor: fullname: Caggia – volume: 13 start-page: 3395 year: 2006 ident: ref_17 article-title: Trends in the development of new drugs for treatment of benign prostatic hyperplasia publication-title: Curr. Med. Chem. doi: 10.2174/092986706779010315 contributor: fullname: Kulig – ident: ref_54 doi: 10.3390/cancers13051158 – volume: 3 start-page: 785 year: 2007 ident: ref_57 article-title: Neurologic uses of botulinum neurotoxin type A publication-title: Neuropsychiatr. Dis. Treat. doi: 10.2147/NDT.S1612 contributor: fullname: Ney – volume: 32 start-page: 22 year: 1997 ident: ref_10 article-title: Role of growth factors in benign prostatic hyperplasia publication-title: Eur. Urol. contributor: fullname: Lawson – volume: 169 start-page: 97 year: 1996 ident: ref_46 article-title: Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and- beta 3 by cultured human prostate cells publication-title: J. Cell Physiol. doi: 10.1002/(SICI)1097-4652(199610)169:1<97::AID-JCP10>3.0.CO;2-L contributor: fullname: Story – volume: 3 start-page: 10 year: 2012 ident: ref_13 article-title: Various treatment options for benign prostatic hyperplasia: A current update publication-title: J. Mid-Life Health doi: 10.4103/0976-7800.98811 contributor: fullname: Shrivastava – volume: 38 start-page: 323 year: 2020 ident: ref_31 article-title: Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm publication-title: World J. Mens. Health doi: 10.5534/wjmh.200012 contributor: fullname: Traish – ident: ref_32 doi: 10.3390/ijms24065904 – volume: 15 start-page: 475 year: 2000 ident: ref_41 article-title: Cellular localization of fibroblast growth factor 2 (FGF-2) in benign prostatic hyperplasia publication-title: Histol. Histopathol. contributor: fullname: Sinowatz – volume: 36 start-page: 403 year: 2009 ident: ref_4 article-title: Etiology, epidemiology, and natural history of benign prostatic hyperplasia publication-title: Urol. Clin. N. Am. doi: 10.1016/j.ucl.2009.07.003 contributor: fullname: Bushman – volume: 2 start-page: 16031 year: 2016 ident: ref_1 article-title: Benign prostatic hyperplasia publication-title: Nat. Rev. Dis. Primers doi: 10.1038/nrdp.2016.31 contributor: fullname: Chughtai – volume: 76 start-page: 643 year: 2023 ident: ref_34 article-title: Is Artificial Intelligence the Key to Revolutionizing Benign Prostatic Hyperplasia Diagnosis and Management publication-title: Arch. Esp. Urol. doi: 10.56434/j.arch.esp.urol.20237609.79 contributor: fullname: Hegazi – ident: ref_25 doi: 10.3390/ijms25094843 – volume: 20 start-page: 17 year: 2017 ident: ref_29 article-title: The role of sex steroid hormones in benign prostatic hyperplasia publication-title: Aging Male doi: 10.1080/13685538.2016.1272101 contributor: fullname: Asiedu – volume: 371 start-page: 106 year: 2019 ident: ref_16 article-title: Revisiting the Pharmacodynamic Uroselectivity of α (1)-Adrenergic Receptor Antagonists publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.119.260216 contributor: fullname: Quaresma – volume: 11 start-page: 126 year: 2020 ident: ref_48 article-title: Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo publication-title: Cell Death Dis. doi: 10.1038/s41419-020-2317-3 contributor: fullname: Fan – volume: 38 start-page: 331 year: 2022 ident: ref_22 article-title: Fimbristylis ovata and Artemisia vulgaris extracts inhibited AGE-mediated RAGE expression, ROS generation, and inflammation in THP-1 cells publication-title: Toxicol. Res. doi: 10.1007/s43188-021-00114-0 contributor: fullname: Sukjamnong – volume: 41 start-page: 110 year: 2015 ident: ref_42 article-title: Insulin-like growth factor (IGF)-I, IGF binding protein-3, and prostate cancer: Correlation with Gleason score publication-title: Int. Braz. J. Urol. doi: 10.1590/S1677-5538.IBJU.2015.01.15 contributor: fullname: Correa – ident: ref_27 doi: 10.3389/fimmu.2023.1196434 – volume: 4 start-page: 441 year: 2013 ident: ref_24 article-title: Prunella vulgaris L.: A literature review on its therapeutic potentials publication-title: Pharmacologia doi: 10.5567/pharmacologia.2013.441.448 contributor: fullname: Rasool – ident: ref_21 doi: 10.3389/fphar.2022.903171 – volume: 86 start-page: 731 year: 2000 ident: ref_44 article-title: Insulin-like growth factor II and androgen receptor expression in the prostate publication-title: BJU Int. doi: 10.1046/j.1464-410x.2000.00874.x contributor: fullname: Gnanapragasam – volume: 3 start-page: 919 year: 2012 ident: ref_55 article-title: Prunella vulgaris aqueous extract attenuates IL-1β-induced apoptosis and NF-κB activation in INS-1 cells publication-title: Exp. Ther. Med. doi: 10.3892/etm.2012.524 contributor: fullname: Wu |
SSID | ssj0057141 |
Score | 2.3967612 |
Snippet | Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men. Prunella vulgaris L. (PV), a perennial... Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men. Prunella vulgaris L. (PV), a perennial... |
SourceID | pubmedcentral proquest crossref |
SourceType | Open Access Repository Aggregation Database |
StartPage | 1516 |
SubjectTerms | Androgens Antioxidants Apoptosis Cancer therapies Cell cycle Cell growth Enzymes Hyperplasia Insulin-like growth factors Kinases Prostate Side effects Testosterone Tuberculosis |
Title | Prunella vulgaris Extract Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating Androgen Levels, Cell Proliferation, and Apoptosis |
URI | https://www.proquest.com/docview/3133131787 https://pubmed.ncbi.nlm.nih.gov/PMC11597678 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BbtNAEF2RnrggSqkaWqqRinqKm27W3l2OIaTKAZAFqdSbtbvepZYSx4obRP6Ez2XGjklz5Wyt19bMet6T37xh7IMY2TghVaPk3EWxEjTIfYRkBaG1MAmG3NMf3dkP9e1Bf56STY7semEa0b6zxU25WN6UxWOjrayWbtjpxIbp1wmiGKyiSg97rIfgsOPo7fc3UTzmrRGpQEI_rB65wgOd0ETz56VnjycP1ZDPysvda_Zqhwth3O5_zF748g27Tltj6e0A5vs-qXoA15DuLae3J-xPut6QXsXArw31ZhQ1TH8_UQMUjJd-QW34CClhTmNkyBlhVfqIhnY4n8MnXxY_S0ip_YPsW2GG1HRdNe2VYLfwvZ1WjyUOSP24woyDLyQ1wueY4J60ckECmSbGAzBlDuNqVeFORf2W3d9N55NZtJu5EDlEFjKyObfCmNwl0sogA7dJCFxZ5wUPMbKxoIUODjmsyrkytx8tje5wufScWxOsOGVHJb7EGQMfh1v6S2t5rGKXeKu1iL3UmhtpkNX02VUXjqxqrTUypCQUtGwftD676CKV7Y5XnQlk1hyRj1Z9pg-i9-9OZJt9eAWzqbHP7rLn3f8vPWcvRwhuqCeR8wt29LTe-PesV-eby4bUXzYZ-Rfpkuz3 |
link.rule.ids | 230,315,729,782,786,866,887,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELXY5QAXvhGF_RgJtKdmW9eJbY7d0lUR3VUEReIWxY69G6lNo2aL6D_h5zKTNHR73bPl2NGzM_OUN28Y-yQGJoxI1Sg5t0GoBDVyHyBZwdRapBFC7uiP7uSHuv6lv4zJJke2tTC1aN-a_LyYL86L_LbWVpYL22t1Yr34aoRZDEZRpXsH7DFe2H6_ZenNFzhSPOSNFalASt8rb7nCKx1RT_P7wWeXUe7rIe8FmMvnD93aC_Zsm1LCsBl_yR654hU7ixtP6k0XZrsSq6oLZxDv3Ko3r9nfeLUmqUsKv9dU1pFXMP5zR7VTMFy4OVXwYzYKM-pAQ6YKy8IF1O_DugwuXJHfFBBT5Qg5v8IEWe2qrCszwWzge9PoHqMjkHByiYcVpqRSwn2McE2aOSdtTX08upAWGQzLZYkr5dUb9vNyPBtNgm27hsBiUiIDk3Ej0jSzkTTSS89N5D1XxjrBfYhEzmuhvUX6qzKu0v5nQ10_bCYd5yb1RrxlhwW-xDsGLvR9-sFreKhCGzmjtQid1JqnMkVC1GEfWxyTsnHlSJDNENrJDu0OO2ohTrY3s0oEknKOSZNWHab3YP__JHLc3h9BtGvn7Rbd9w-fesqeTGZX02T69frbB_Z0gDkSlTZyfsQO71Zrd8wOqmx9Uh_of0zwAdY |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nj9MwELXYRUJc-EYUFhgJtKdmU9dJbLiVbqsillUEReIW2Y7NRmrTqNki-k_4ucwkDd1e4ZwPO3p2Zp785g1jb8XQRDGpGhPObRBJQY3ch0hWMLUWOkbIHZ3ozr7Ky-_qfEI2Oe-7WphGtG9NcVYulmdlcdVoK6ulDTudWJh-HmMWg1FUqrDKfXjEbuOmHQw7pt7-hWPJI97akQqk9WF1xSVu65j6mt8MQPus8lATeSPITO__z_QesHu71BJG7T0P2S1XPmKnaetNve3DfF9qVffhFNK9a_X2MfudrjckedHwc0PlHUUNk1_XVEMFo6VbUCU_ZqUwp040ZK6wKl1AfT-sy-GDK4sfJaRUQUIOsDBDdruumgpNMFv40ja8xygJJKBc4aKFC1Ir4TzGOCY9uSCNTbNM-qDLHEbVqsKRivoJ-zadzMezYNe2IbCYnCSBybkRWuc2TkziE89N7D2XxjrBfYSEziuhvEUaLHMu9eCdoe4fNk8c50Z7I56y4xI_4hkDF_kBHfQaHsnIxs4oJSKXKMV1opEY9dibDsusat05MmQ1hHi2R7zHTjqYs90OrTOB5Jxj8qRkj6kD6P--iZy3D68g4o0Dd4fw839_9DW7k55Ps4uPl59esLtDTJWowpHzE3Z8vd64l-yozjevmjX9BzjHBFY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prunella+vulgaris+Extract+Ameliorates+Testosterone-Induced+Benign+Prostatic+Hyperplasia+by+Regulating+Androgen+Levels%2C+Cell+Proliferation%2C+and+Apoptosis&rft.jtitle=Pharmaceuticals+%28Basel%2C+Switzerland%29&rft.au=Kumbukgahadeniya%2C+Poornima&rft.au=Eun-Bok+Baek&rft.au=Eun-Ju%2C+Hong&rft.au=Jun-Yeop+Song&rft.date=2024-11-11&rft.pub=MDPI+AG&rft.eissn=1424-8247&rft.volume=17&rft.issue=11&rft.spage=1516&rft_id=info:doi/10.3390%2Fph17111516&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1424-8247&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1424-8247&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1424-8247&client=summon |